{
    "paper_id": "PMC6701119",
    "metadata": {
        "title": "Evaluating respiratory cryptosporidiosis in pediatric diarrheal disease: protocol for a prospective, observational study in Malawi",
        "authors": [
            {
                "first": "Wongani",
                "middle": [],
                "last": "Nyangulu",
                "suffix": "",
                "email": "wnyangulu@mlw.mw",
                "affiliation": {}
            },
            {
                "first": "Wes",
                "middle": [],
                "last": "Van Voorhis",
                "suffix": "",
                "email": "wesley@uw.edu",
                "affiliation": {}
            },
            {
                "first": "Pui-Ying",
                "middle": [],
                "last": "Iroh Tam",
                "suffix": "",
                "email": "irohtam@mlw.mw",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Studies have identified Cryptosporidium spp. in sputum but have not looked at whether respiratory involvement is a transient phenomenon or a reservoir for gastrointestinal (GI) disease. Our study is unique in that this is the first longitudinal study to evaluate for pulmonary and GI Cryptosporidium concurrently. If respiratory cryptosporidiosis is established to be a reservoir for diarrheal disease, findings would inform the development of systemic therapeutic interventions against Cryptosporidium.",
            "cite_spans": [],
            "section": "Rationale ::: Background",
            "ref_spans": []
        },
        {
            "text": "The main study hypothesis is that pulmonary Cryptosporidium can be a nidus of infection for Cryptosporidium. Secondly, we hypothesize that pulmonary and GI Cryptosporidium will lead to worse outcomes (mortality, stunting) than those with only GI Cryptosporidium.",
            "cite_spans": [],
            "section": "Rationale ::: Background",
            "ref_spans": []
        },
        {
            "text": "The primary objectives are: (1) To estimate the proportion of young children on admission hospitalized with Cryptosporidium diarrhea that have Cryptosporidium detected from the respiratory tract; and (2) To evaluate the longitudinal pattern of pulmonary cryptosporidiosis in children hospitalized with Cryptosporidium diarrhea.",
            "cite_spans": [],
            "section": "Primary objectives ::: Study objectives",
            "ref_spans": []
        },
        {
            "text": "The secondary objectives are: (1) To identify risk factors for respiratory cryptosporidiosis in children with diarrhea; (2) To determine the proportion of children with diarrhea and with Cryptosporidium in the respiratory tract that have associated respiratory symptoms; and (3) To determine the detection rate of Cryptosporidium in the GI and respiratory tract, and longitudinally, detection in one tract or the other and the relationship to respiratory and GI symptoms.",
            "cite_spans": [],
            "section": "Secondary objectives ::: Study objectives",
            "ref_spans": []
        },
        {
            "text": "The presence of Cryptosporidium spp. in sputum/NP swab and stool.",
            "cite_spans": [],
            "section": "Primary outcomes ::: Study objectives",
            "ref_spans": []
        },
        {
            "text": "The presence of respiratory and GI symptoms, mortality and stunting.",
            "cite_spans": [],
            "section": "Secondary outcomes ::: Study objectives",
            "ref_spans": []
        },
        {
            "text": "This prospective, observational and longitudinal study will evaluate the role of respiratory cryptosporidiosis in pediatric diarrheal disease.",
            "cite_spans": [],
            "section": "Study type ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "The primary site for this study is QECH located in Blantyre, Malawi. Subjects will be recruited from the Pediatric Accident and Emergency and pediatric wards at QECH. If recruitment targets are not met at QECH, recruitment will be expanded to secondary sites including Blantyre District Health Office health centers and Chikwawa District Hospital in Chikwawa, Malawi.",
            "cite_spans": [],
            "section": "Study location ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Young children 2\u201324 months of age hospitalized with a primary diagnosis of diarrhea will be enrolled into the study, provided parents/ guardians complete the informed consent process and children fulfill all the inclusion and exclusion criteria.",
            "cite_spans": [],
            "section": "Study population ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "\nInclusion criteria\nMale or femaleAge 2\u201324 monthsHospitalized with diarrhea (defined as 3 or more loose stools within 24 h)Lives within 15 km radius of Blantyre districtPositive on sputum/NP swab or stool for Cryptosporidium by PCRParent/guardian consent for enrollment\n",
            "cite_spans": [],
            "section": "Study population ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "\nExclusion criteria\nDysentery (visible blood in loose stool)\n",
            "cite_spans": [],
            "section": "Study population ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Persons screened for study entry will be those presenting with primary GI symptoms to QECH and/or health centers in Blantyre or Chikwawa region, and who are eligible for hospitalization. Eligible patients meet all the inclusion and none of the exclusion criteria.",
            "cite_spans": [],
            "section": "Recruitment ::: Study procedures ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Subjects for this study will be recruited from the study site by word of mouth. Patients attending clinics other than health centers or district hospitals with inpatient facilities will be informed about the study at Triage. Before any study related activities, the study team will obtain informed consent.",
            "cite_spans": [],
            "section": "Recruitment ::: Study procedures ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Following admission and after obtaining informed consent, an electronic folder will be created on tablet computers for potential participants. Data collected will include demographic information, medical history, physical examination and results of relevant investigations performed as part of routine care (including full blood count (FBC), urea and electrolytes (U&E), and liver function tests (LFTs), malaria parasite screen, blood and/or CSF culture, TB GeneXpert and acid fast bacilli (AFB) testing). All HIV exposed infants will have HIV DNA PCR done.",
            "cite_spans": [],
            "section": "Screening ::: Study procedures ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "All enrolled patients will have induced sputum/NP swab and stool samples collected. Induced sputum will only be collected if there are no contraindications (based on PERCH criteria for induced sputum collection): severe hypoxia < 92% on supplemental oxygen; inability to protect airways; severe bronchospasm at admission (defined as continued hypoxia < 92% after appropriate bronchodilator therapy, with other markers of respiratory distress); seizure within the past 24 h; deemed inappropriate by the clinician for another reason (e.g. midface trauma, inhalational injury, pulmonary effusion, congestive heart failure, congenital heart disease, etc.). If the above symptoms/conditions resolve during the hospital course, induced sputum collection may be reconsidered at that point.",
            "cite_spans": [],
            "section": "Screening ::: Study procedures ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "The induced sputum procedure will be as follows. Subjects will be given a nebulized \u03b2-agonist (salbutamol) followed by 3% sodium chloride mist to inhale for 5\u201315 min. A sterile catheter will then be passed through the nose into the posterior nasopharynx and suction applied to aspirate contents. If the child does not tolerate the procedure or has an adverse reaction, the procedure will be discontinued and the child will be monitored up to 4 h post procedure. Once stabilized, and parents are amenable, the induced sputum collection can be attempted 24 h later.",
            "cite_spans": [],
            "section": "Sampling procedures ::: Study procedures ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Quality of sputum will be documented by microscopy (good quality: \u226410 squamous epithelial cells/low powered field). The first 100 subjects screened will also have NP swab collected in addition to induced sputum, in order to compare the yield of Cryptosporidium detection between these two specimen types. If the yield is deemed equivalent, subsequent respiratory tract sampling after the first 100 subjects will include only NP swabs. All sputum and stool specimens from recruited subjects will also be subjected to multiplex testing for multiple pathogens but the results will not be returned by enrollment.",
            "cite_spans": [],
            "section": "Sampling procedures ::: Study procedures ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "If the patient remains hospitalized for longer than a week then sputum/NP swabs and stool samples will be collected weekly until discharge. With each sample collection, the patients will be assessed for symptoms and results from relevant laboratory investigations performed as part of routine care will be recorded. At discharge, the patients will be assessed for symptoms but no specimens will be collected.",
            "cite_spans": [],
            "section": "Sampling procedures ::: Study procedures ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Participants that are positive for Cryptosporidium on NP/sputum/stool testing will continue to be followed up in the study (Table 1). They will be instructed to return to the clinic for a follow-up visit fortnightly for evaluation of symptoms, physical assessment, as well as sputum/NP and stool sampling. A final follow up visit will be scheduled approximately 8 weeks after discharge for final evaluation of symptoms, physical assessment, and sputum/NP and stool sampling. Table 2 provides an overview of all study visits and scheduled study events.\n\n",
            "cite_spans": [],
            "section": "Enrollment and follow-up ::: Study procedures ::: Methods/design",
            "ref_spans": [
                {
                    "start": 130,
                    "end": 131,
                    "mention": "1",
                    "ref_id": "TABREF0"
                },
                {
                    "start": 481,
                    "end": 482,
                    "mention": "2",
                    "ref_id": "TABREF1"
                }
            ]
        },
        {
            "text": "All participating children will be tested for HIV on admission by QECH HIV testing counselors. These are part of routine care and so will enhance the management of these individuals. In line with national guidelines, HIV testing will be with 2 complementary rapid tests (UniGold\u2122 and Determine\u2122) according to manufacturers\u2019 instructions. As HIV antibody testing is not a reliable marker of HIV status in infants until about 18 months of age, we will perform HIV DNA PCR testing on all recruited children < 18 months with a positive HIV test.",
            "cite_spans": [],
            "section": "HIV testing ::: Laboratory processing ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Induced sputum collection will be done in a well-ventilated room (at QECH, this will be a patient procedure room in the Paediatric Research Ward) equipped with an emergency tray. Quality of the sputum will be documented by microscopy. All participating children will have admission sputum and stool specimens evaluated for Cryptosporidium, by Cryptosporidium PCR for sputum or the TaqMan assay for stool, in batched testing. Only the admission specimens that are positive for Cryptosporidium in either sputum or stool will have all subsequent specimens processed for multiplex testing. Multiplex testing on sputum will test for bacteria (S. pneumoniae, S. aureus, M. catarrhalis, B. pertussis, H. influenzae and H. influenzae type b, C. pneumoniae, M. pneumoniae, K. pneumoniae, L. pneumophila, and Salmonella species); viruses (influenza A/B/C, RSV A/B, parainfluenza virus types 1\u20134, coronaviruses NL63, 229E, OC43, and HKU1, human metapneumovirus A/B, rhinovirus, adenovirus, enterovirus, parechovirus, bocavirus, cytomegalovirus); and parasites (P. jirovecii). Multiplex testing of stool will test for viruses (rotavirus, norovirus GII, adenovirus, astrovirus, sapovirus), bacteria (enterotoxigenic Escherichia coli (ETEC), enteropathogenic E. coli (EPEC), enteroaggregative E. coli (EAEC), Shiga-toxigenic E. coli (STEC), Shigella/enteroinvasive E. coli, Salmonella, Campylobacter jejuni, C. coli, Vibrio cholerae, Clostridium difficile), and parasites (Cryptosporidium, Giardia lamblia, Entamoeba histolytica, Ascaris lumbricoides, and Trichuris trichiura).",
            "cite_spans": [],
            "section": "Induced sputum and stool processing ::: Laboratory processing ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "About 250 subjects will be screened. Various studies identified Cryptosporidium diarrhea in 12.5\u201313.8% of children [2, 5]. Therefore, with a sample size of 250 children, we anticipate 30\u201335 to have positive stool samples at admission.",
            "cite_spans": [
                {
                    "start": 116,
                    "end": 117,
                    "mention": "2",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 119,
                    "end": 120,
                    "mention": "5",
                    "ref_id": "BIBREF6"
                }
            ],
            "section": "Sample size ::: Statistical analysis ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "The primary endpoints (detection of Cryptosporidium in stool, sputum) are binary. Frequencies and proportions of observed levels will be reported for binary and categorical variables, with exact binomial 95% confidence intervals given where appropriate. For all continuous variables we will report the population size, the non-missing sample size, the mean, and standard deviation, median, minimum, maximum and interquartile range. Age distribution will be reported as a categorical variable with age bands defined as 2\u201311 months and 12\u201324 months.",
            "cite_spans": [],
            "section": "Analysis ::: Statistical analysis ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Based on a planned sample size of 250 children, to estimate proportions we expect to achieve the absolute margins of error given in Table 3 for different values of proportions and sample sizes of children hospitalized with Cryptosporidium diarrhea.\n",
            "cite_spans": [],
            "section": "Analysis ::: Statistical analysis ::: Methods/design",
            "ref_spans": [
                {
                    "start": 138,
                    "end": 139,
                    "mention": "3",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "For Objective 1a, based on the Mor et al. paper we expect 14.7\u201335.4% of recruited subjects with diarrhea to have Cryptosporidium in stool and sputum at admission (4\u201312 sputum-positive out of a total of 35 stool-positive).",
            "cite_spans": [],
            "section": "Analysis ::: Statistical analysis ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "For Objective 1b, we expect the proportion to be higher. If the estimated proportion is 35% and we estimate this proportion from n = 30 children hospitalized with Cryptosporidium diarrhea, then we can estimate this proportion with an absolute margin of error of 18% (exact binomial 95% confidence interval [17, 53%]).",
            "cite_spans": [],
            "section": "Analysis ::: Statistical analysis ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "For Objective 2, we do not have an expected estimate as our study will be the first to look at this. However, Table 3 gives a range of proportions between 15 and 50%.",
            "cite_spans": [],
            "section": "Analysis ::: Statistical analysis ::: Methods/design",
            "ref_spans": [
                {
                    "start": 116,
                    "end": 117,
                    "mention": "3",
                    "ref_id": "TABREF2"
                }
            ]
        },
        {
            "text": "Time to subsequent detection in the respiratory tract or GI tract will be evaluated using time-to-event analysis methods for interval-censored data. Specifically, we will use non-parametric maximum likelihood estimators and generalized log-rank tests for unadjusted analyses and Cox regression for adjusted analyses.",
            "cite_spans": [],
            "section": "Analysis ::: Statistical analysis ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Comparisons between groups of patients (defined by age band, HIV status, etc.) will be performed using the exact Fisher test for binary and categorical variables, t-test (two groups) or ANOVA (three or more groups) for approximately normally distributed variables and Wilcoxon rank sum (2 groups) or Kruskal-Wallis (3 or more groups) tests for variables with severely non-normal distributions. To evaluate outcomes longitudinally we will use mixed models for data with patient ID treated as a random factor.",
            "cite_spans": [],
            "section": "Analysis ::: Statistical analysis ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Data will be collected onto standard proformas and all records will be held securely in MLW project offices. Proformas will be destroyed after 10 years. Each study participant will be assigned a unique study number at enrolment. Demographics and relevant medical history will be collected on a structured case record form (CRF) that will be electronically captured (ODK system) and stored on a password-protected database. Data files (anonymized) will be exported to Stata (Statacorp, USA) for analysis.",
            "cite_spans": [],
            "section": "Data safety and monitoring ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "All data will be acquired and validated by the MLW data team. All databases will be protected by passwords. The only sources of person-identifiable information will be the consent form, enrollment log, and the participant tracking form. The latter will detail the subjects\u2019 name, contact details and the unique study number, in order to provide a link with the anonymized clinical data. The paper copy will be kept in a secured locked cabinet held separately from the CRF hard copies. The electronic copy will be stored in a password-protected database. Only authorized study personnel will have access to this information.",
            "cite_spans": [],
            "section": "Data safety and monitoring ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "The study will be monitored by an internal monitoring committee, Malawi-Liverpool Wellcome Trust (MLW) Clinical Research Support Unit (CRSU) and the University of Malawi College of Medicine Research and Ethics Committee (COMREC).",
            "cite_spans": [],
            "section": "Data safety and monitoring ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Subjects for this study will be recruited from the study site by word of mouth. Patients attending clinics other than health centers or district hospitals with inpatient facilities will be informed about the study at triage. A poster will be placed at each clinic announcing the study. All study procedures will be performed at QECH, health centers or district hospitals with inpatient facilities.",
            "cite_spans": [],
            "section": "Recruitment ::: Ethical considerations ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "After meeting inclusion/exclusion criteria and providing documented informed consent forms (ICF), subjects will be screened using a PCR for the presence of Cryptosporidium infection. Subjects testing positive for Cryptosporidium infection will continue participation in the longitudinal phase of the study. The longitudinal phase of the study will be explained and discussed with the subject at the time of enrollment, and will be reviewed with the patient if they test positive.",
            "cite_spans": [],
            "section": "Recruitment ::: Ethical considerations ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Young children will be recruited. Before any study-related activities and in agreement with applicable regulatory requirements, the Investigator will ensure that the subject and parent/guardian is fully informed about the aims, procedures, potential risks, and potential benefits of the study. The subject\u2019s parent/guardian will be given the written, IRB-approved ICF, allowed ample time to read the consent form, allowed to ask questions about the study, have their questions answered and then be given time to decide if s/he would like her child to participate in the study. It will be emphasized that participation is voluntary, and that the subject has the right to withdraw from the study at any time without prejudice.",
            "cite_spans": [],
            "section": "Informed consent process ::: Ethical considerations ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "For enrollment into the study, the subject\u2019s parent/guardian will need to sign an ICF. The Investigator will obtain the parent/guardian\u2019s voluntary, personally signed and dated ICF before any study-related procedure can be conducted. The original, signed ICF(s) will be kept in the site study file. Subjects volunteering to participate in this study will be compensated for their time according to the terms specified by COMREC. Specifically, they will be given the equivalent of USD 10 in Malawi Kwacha to cover transport expenses when asked to visit the hospital for study-related procedures when participating in the specimen collection segment of the protocol, and additional payment for their time when admitted in the hospital for study-related procedures and for transport expenses for the five follow up visits.",
            "cite_spans": [],
            "section": "Informed consent process ::: Ethical considerations ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Parents or guardians will be given written, IRB-approved informed consent forms in English or Chichewa, allowed ample time to read the consent form, allowed to ask questions about the study, have their questions answered and given time to decide if s/he would like their child to participate in the study. The informed consent will be read verbally in Chichewa to those who are unable to read. This will be done in the presence of an impartial witness who will also sign the consent form. After reading or listening, the potential participant is asked to sign the informed consent form. For those who cannot write, a thumbprint will be placed on the form with the signature of the witness and date. After obtaining informed consent, participants will be given a signed copy of the informed consent document and assigned a screening identification number.",
            "cite_spans": [],
            "section": "Informed consent process ::: Ethical considerations ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "Results will be presented to the QECH Department of Pediatrics research meeting, and may be presented at local/regional/international conferences and published in a peer-reviewed journal.",
            "cite_spans": [],
            "section": "Dissemination of results ::: Risk/benefit ::: Methods/design",
            "ref_spans": []
        },
        {
            "text": "The study began recruitment in February 2019. At the beginning of May 2019, 52 patients had been screened with 14 patients PCR positive for cryptosporidium in stool or sputum, a higher than expected recruitment return at this stage of the study. We attribute this to higher local prevalence of cryptosporidium (27.8%) compared to other studies of cryptosporidium in children (12.5\u201313.8%) [7, 11]. We expect a drop-off in screening and recruitment as the rainy season ends with a resurgence in the next rainy season.",
            "cite_spans": [
                {
                    "start": 389,
                    "end": 390,
                    "mention": "7",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 392,
                    "end": 394,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Study status ::: Discussion",
            "ref_spans": []
        },
        {
            "text": "Fifty-one of the fifty-two enrolled participants have undergone induced sputum collection. None had contraindications to the procedure at initial contact. No adverse events or severe adverse events have been detected or reported so far. A sub study evaluating safety of induced sputum collection in Malawian children is also being conducted. This will further add to evidence on safety of induced sputum collection and optimum follow up time after the procedure, data essential to adoption of induced sputum collection in non-research settings (public hospitals).",
            "cite_spans": [],
            "section": "Participant safety ::: Discussion",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Overview of study visits\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Summary of study events schedule\naWill be performed on all infants < 18 months who are positive on rapid HIV test bSubset of those positive on sputum/NP swab or stool for Cryptosporidium PCR on admission",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table 3: Absolute margins of error for different values of proportions and sample sizes of children hospitalized with Cryptosporidium diarrhea, based on a sample size of 250\n",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)",
            "authors": [
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Platts-Mills",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Babji",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bodhidatta",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gratz",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Haque",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Havt",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Lancet Glob Health",
            "volume": "3",
            "issn": "9",
            "pages": "e564-e575",
            "other_ids": {
                "DOI": [
                    "10.1016/S2214-109X(15)00151-5"
                ]
            }
        },
        "BIBREF1": {
            "title": "Safety of induced sputum collection in children hospitalized with severe or very severe pneumonia",
            "authors": [
                {
                    "first": "AN",
                    "middle": [],
                    "last": "DeLuca",
                    "suffix": ""
                },
                {
                    "first": "LL",
                    "middle": [],
                    "last": "Hammitt",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "MM",
                    "middle": [],
                    "last": "Higdon",
                    "suffix": ""
                },
                {
                    "first": "HC",
                    "middle": [],
                    "last": "Baggett",
                    "suffix": ""
                },
                {
                    "first": "WA",
                    "middle": [],
                    "last": "Brooks",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Clin Infect Dis",
            "volume": "64",
            "issn": "suppl_3",
            "pages": "S301-S308",
            "other_ids": {
                "DOI": [
                    "10.1093/cid/cix078"
                ]
            }
        },
        "BIBREF2": {
            "title": "The pneumonia etiology research for child health project: a 21st century childhood pneumonia etiology study",
            "authors": [
                {
                    "first": "OS",
                    "middle": [],
                    "last": "Levine",
                    "suffix": ""
                },
                {
                    "first": "KL",
                    "middle": [],
                    "last": "O\u2019Brien",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Deloria-Knoll",
                    "suffix": ""
                },
                {
                    "first": "DR",
                    "middle": [],
                    "last": "Murdoch",
                    "suffix": ""
                },
                {
                    "first": "DR",
                    "middle": [],
                    "last": "Feikin",
                    "suffix": ""
                },
                {
                    "first": "AN",
                    "middle": [],
                    "last": "DeLuca",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Clin Infect Dis an Off Publ Infect Dis Soc Am",
            "volume": "54",
            "issn": "Suppl 2",
            "pages": "S93-101",
            "other_ids": {
                "DOI": [
                    "10.1093/cid/cir1052"
                ]
            }
        },
        "BIBREF3": {
            "title": "Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study",
            "authors": [
                {
                    "first": "KL",
                    "middle": [],
                    "last": "Kotloff",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Nataro",
                    "suffix": ""
                },
                {
                    "first": "WC",
                    "middle": [],
                    "last": "Blackwelder",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Nasrin",
                    "suffix": ""
                },
                {
                    "first": "TH",
                    "middle": [],
                    "last": "Farag",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Panchalingam",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Lancet (London, England)",
            "volume": "382",
            "issn": "9888",
            "pages": "209-222",
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(13)60844-2"
                ]
            }
        },
        "BIBREF4": {
            "title": "Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, West Africa",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Molbak",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Hojlyng",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Gottschau",
                    "suffix": ""
                },
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Sa",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ingholt",
                    "suffix": ""
                },
                {
                    "first": "AP",
                    "middle": [],
                    "last": "da Silva",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "BMJ.",
            "volume": "307",
            "issn": "6901",
            "pages": "417-420",
            "other_ids": {
                "DOI": [
                    "10.1136/bmj.307.6901.417"
                ]
            }
        },
        "BIBREF5": {
            "title": "Natural history of cryptosporidiosis in a longitudinal study of slum-dwelling Bangladeshi children: association with severe malnutrition",
            "authors": [
                {
                    "first": "PS",
                    "middle": [],
                    "last": "Korpe",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Haque",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Gilchrist",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Valencia",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Niu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "PLoS Negl Trop Dis",
            "volume": "10",
            "issn": "5",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.pntd.0004564"
                ]
            }
        },
        "BIBREF6": {
            "title": "Respiratory cryptosporidiosis in HIV-seronegative children in Uganda: potential for respiratory transmission",
            "authors": [
                {
                    "first": "SM",
                    "middle": [],
                    "last": "Mor",
                    "suffix": ""
                },
                {
                    "first": "JK",
                    "middle": [],
                    "last": "Tumwine",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ndeezi",
                    "suffix": ""
                },
                {
                    "first": "MG",
                    "middle": [],
                    "last": "Srinivasan",
                    "suffix": ""
                },
                {
                    "first": "DH",
                    "middle": [],
                    "last": "Kaddu-Mulindwa",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tzipori",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Clin Infect Dis an Off Publ Infect Dis Soc Am",
            "volume": "50",
            "issn": "10",
            "pages": "1366-1372",
            "other_ids": {
                "DOI": [
                    "10.1086/652140"
                ]
            }
        },
        "BIBREF7": {
            "title": "The evolution of respiratory cryptosporidiosis: evidence for transmission by inhalation",
            "authors": [
                {
                    "first": "JK",
                    "middle": [],
                    "last": "Sponseller",
                    "suffix": ""
                },
                {
                    "first": "JK",
                    "middle": [],
                    "last": "Griffiths",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tzipori",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Clin Microbiol Rev",
            "volume": "27",
            "issn": "3",
            "pages": "575-586",
            "other_ids": {
                "DOI": [
                    "10.1128/CMR.00115-13"
                ]
            }
        },
        "BIBREF8": {
            "title": "Aetiology of diarrhoea among hospitalised children in Blantyre, Malawi following rotavirus vaccine introduction: a case-control study",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Iturriza-Gomara",
                    "suffix": ""
                },
                {
                    "first": "KC",
                    "middle": [],
                    "last": "Jere",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Hungerford",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Bar-Zeev",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Shioda",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Kanjerwa",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Infect Dis",
            "volume": "220",
            "issn": "2",
            "pages": "213-8",
            "other_ids": {
                "DOI": [
                    "10.1093/infdis/jiz084"
                ]
            }
        },
        "BIBREF9": {
            "title": "Incidence of cryptosporidiosis species in paediatric patients in Malawi",
            "authors": [
                {
                    "first": "TD",
                    "middle": [],
                    "last": "Morse",
                    "suffix": ""
                },
                {
                    "first": "RAB",
                    "middle": [],
                    "last": "Nichols",
                    "suffix": ""
                },
                {
                    "first": "AM",
                    "middle": [],
                    "last": "Grimason",
                    "suffix": ""
                },
                {
                    "first": "BM",
                    "middle": [],
                    "last": "Campbell",
                    "suffix": ""
                },
                {
                    "first": "KC",
                    "middle": [],
                    "last": "Tembo",
                    "suffix": ""
                },
                {
                    "first": "HV",
                    "middle": [],
                    "last": "Smith",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Epidemiol Infect",
            "volume": "135",
            "issn": "8",
            "pages": "1307-1315",
            "other_ids": {
                "DOI": [
                    "10.1017/S0950268806007758"
                ]
            }
        },
        "BIBREF10": {
            "title": "Procedures for collection of induced sputum specimens from children",
            "authors": [
                {
                    "first": "LR",
                    "middle": [],
                    "last": "Grant",
                    "suffix": ""
                },
                {
                    "first": "LL",
                    "middle": [],
                    "last": "Hammitt",
                    "suffix": ""
                },
                {
                    "first": "DR",
                    "middle": [],
                    "last": "Murdoch",
                    "suffix": ""
                },
                {
                    "first": "KL",
                    "middle": [],
                    "last": "O\u2019Brien",
                    "suffix": ""
                },
                {
                    "first": "JA",
                    "middle": [],
                    "last": "Scott",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Clin Infect Dis an Off Publ Infect Dis Soc Am",
            "volume": "54",
            "issn": "Suppl 2",
            "pages": "S140-S145",
            "other_ids": {
                "DOI": [
                    "10.1093/cid/cir1069"
                ]
            }
        }
    }
}